Biotech

All Articles

Amgen reports initial stage 3 win for $400M chronic eczema medication

.Amgen has actually shared (PDF) the initial phase 3 information on its $400 thousand eczema drug, c...

Biogen, UCB file period 3 lupus win after stopping working earlier test

.Biogen as well as UCB's depend improving in to phase 3 on the back of a failed research wants to ha...

Aptadir hopes new RNA preventions can reverse difficult cancers cells

.Italian biotech Aptadir Rehabs has introduced with the assurance that its pipe of preclinical RNA p...

Wave surfs DMD excellence to regulators' doors, sending out stock up

.Surge Life Sciences has satisfied its target in a Duchenne muscular dystrophy (DMD) study, placing ...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, using u...

Achilles splashes tissue therapy system, braces for unemployments after missing out on 'industrial stability' targets

.Achilles Therapeutics has actually wrecked its own method. The English biotech is actually stopping...

Aligos proclaims phase 2 MASH gain, reducing liver body fat as much as 46%

.Aligos Rehabs is proclaiming a midstage succeed in metabolic-dysfunction connected steatohepatitis ...

Basilea ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work building brand-new antifungals has acquired a substantial increase com...

Capricor sells Europe civil liberties to late-stage DMD treatment for $35M

.Possessing currently scooped up the USA rights to Capricor Therapies' late-stage Duchenne muscular ...

FDA fragments adcomm for Applied's uncommon condition medicine

.After pushing the decision meeting for Applied Rehabs' metabolic condition medication govorestat, t...